Evaluation of the INNO-BIA Plasma A Forms (INNOGENETICS) Commercial Kit for the Measurement of Beta Amyloid 40, 42, n-40 and n-42 in Human Plasma and SerumBackground: The validation of a commercial multiplexing kit for the quantification of A尾 isoforms (1-40, 1-42, n-40 and n-42)...
Deleersnijder, WillyTrojanowski, JohnIwatsubo, TakeshiShaw, LeslieAlzheimers & DementiaVandijck M, Kuwano R, Waligorska T, De Smet S, Tsukie T, Verdoodt L, et al. Inter-laboratory variation when using a unified test procedure for INNO-BIA AlzBio3. Alzheimers Dement 2013; 9(Supplement 4)...
First Multicenter Qualification of an Assay (INNO-BIA Plasma A Forms Assay) for Measurement of -amyloid Proteins as Part of US-ADNI Efforts for Biomarker QualificationBackground: Accurate and reliable measurement of ß-amyloid proteins (Aß) in blood is a challenging goal. The lack of ...
P-064: Measurement of β-amyloid isoforms in human plasma using the INNO-BIA plasma Aβ forms:(Pre)-clinical validationdoi:10.1016/j.jalz.2007.04.317Hugo M. VandersticheleINNOGENETICS, Gent, Belgium;INNOGENETICS, Zwijnaarde, Belgium.;Leen Demeyer...
P-057 : Validation of the xMAP technology and performance of INNO-BIA AlzBio3 for quantification in CSF of Aβ1-42, total tau and P-tau181pEscherichia coliDNA GlycosylasesN-Glycosyl HydrolasesRestriction MappingCloning, MolecularGenetic Complementation TestDNA Repair...
Dean R, Shaw LM, Waligorska TW, Korecka M, Figurski M, Trojanowski J, et al. Inclusion of patients with Alzheimer's disease pathology in solanezumab expedition 3 using florbetapir PET imaging or INNO-BIA AlzBio3 CSF Aβ1-42. Alzheimers Dement. 2014;10:P811....